Literature DB >> 33396472

The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders.

Wu Jeong Hwang1, Tae Young Lee2,3, Nahrie Suk Kim2, Jun Soo Kwon1,4.   

Abstract

Increasing evidence suggests estrogen and estrogen signaling pathway disturbances across psychiatric disorders. Estrogens are not only crucial in sexual maturation and reproduction but are also highly involved in a wide range of brain functions, such as cognition, memory, neurodevelopment, and neuroplasticity. To add more, the recent findings of its neuroprotective and anti-inflammatory effects have grown interested in investigating its potential therapeutic use to psychiatric disorders. In this review, we analyze the emerging literature on estrogen receptors and psychiatric disorders in cellular, preclinical, and clinical studies. Specifically, we discuss the contribution of estrogen receptor and estrogen signaling to cognition and neuroprotection via mediating multiple neural systems, such as dopaminergic, serotonergic, and glutamatergic systems. Then, we assess their disruptions and their potential implications for pathophysiologies in psychiatric disorders. Further, in this review, current treatment strategies involving estrogen and estrogen signaling are evaluated to suggest a future direction in identifying novel treatment strategies in psychiatric disorders.

Entities:  

Keywords:  attention-deficit/hyperactivity disorder; autism; bipolar disorder; estrogen; estrogen receptors; hypothalamic-pituitary-gonadal axis; major depression disorder; raloxifene; schizophrenia

Mesh:

Substances:

Year:  2020        PMID: 33396472      PMCID: PMC7794990          DOI: 10.3390/ijms22010373

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  216 in total

Review 1.  Selective estrogen receptor modulators as brain therapeutic agents.

Authors:  María Angeles Arevalo; María Santos-Galindo; Natalia Lagunas; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  J Mol Endocrinol       Date:  2011-01-19       Impact factor: 5.098

2.  Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.

Authors:  Jayashri Kulkarni; Emorfia Gavrilidis; Stella M Gwini; Roisin Worsley; Jasmin Grigg; Annabelle Warren; Caroline Gurvich; Heather Gilbert; Michael Berk; Susan R Davis
Journal:  JAMA Psychiatry       Date:  2016-09-01       Impact factor: 21.596

Review 3.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 4.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

5.  Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques.

Authors:  C L Bethea; S J Mirkes; C A Shively; M R Adams
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

Review 6.  Contribution of sex hormones to gender differences in schizophrenia: A review.

Authors:  Tricia L da Silva; Arun V Ravindran
Journal:  Asian J Psychiatr       Date:  2015-08-01

7.  Clinical characteristics of women with reproductive cycle-associated bipolar disorder symptoms.

Authors:  Tania A Perich; Gloria Roberts; Andrew Frankland; Carina Sinbandhit; Tanya Meade; Marie-Paul Austin; Philip B Mitchell
Journal:  Aust N Z J Psychiatry       Date:  2016-09-30       Impact factor: 5.744

8.  Serum levels of G protein-coupled estrogen receptor 1 (GPER1) in drug-naive patients with generalized anxiety disorder.

Authors:  Ebru Fındıklı; Mehmet Akif Camkurt; Mehmet Fatih Karaaslan; Ergul Belge Kurutas; Hatice Altun; Filiz İzci; Hüseyin Avni Fındıklı; Selçuk Kardas
Journal:  Psychiatry Res       Date:  2016-07-22       Impact factor: 3.222

9.  Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.

Authors:  T W Weickert; D Weinberg; R Lenroot; S V Catts; R Wells; A Vercammen; M O'Donnell; C Galletly; D Liu; R Balzan; B Short; D Pellen; J Curtis; V J Carr; J Kulkarni; P R Schofield; C S Weickert
Journal:  Mol Psychiatry       Date:  2015-05-18       Impact factor: 15.992

10.  The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation.

Authors:  Zengli Zhang; Pei Qin; Youliang Deng; Zhi Ma; Hang Guo; Haiyun Guo; Yushu Hou; Shiquan Wang; Wangyuan Zou; Yanyuan Sun; Yulong Ma; Wugang Hou
Journal:  J Neuroinflammation       Date:  2018-07-12       Impact factor: 8.322

View more
  12 in total

1.  Relevance of c-Src and protein phosphatase 2A to aromatase activity: Evidence of an acute self-regulating oestrogenic signalling complex in rat central nervous system.

Authors:  Emiliya M Storman; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neuroendocrinol       Date:  2022-01-18       Impact factor: 3.870

2.  Prenatal Exposure to Triclocarban Impairs ESR1 Signaling and Disrupts Epigenetic Status in Sex-Specific Ways as Well as Dysregulates the Expression of Neurogenesis- and Neurotransmitter-Related Genes in the Postnatal Mouse Brain.

Authors:  Agnieszka Wnuk; Joanna Rzemieniec; Karolina Przepiórska; Bernadeta Angelika Pietrzak; Marzena Maćkowiak; Małgorzata Kajta
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

Review 3.  Potential Role of Curcumin for the Treatment of Major Depressive Disorder.

Authors:  Adrian L Lopresti
Journal:  CNS Drugs       Date:  2022-02-07       Impact factor: 5.749

4.  Identification of Potential Key circRNAs in Aged Mice With Postoperative Delirium.

Authors:  Wei Ran; Ning Liang; Ruixue Yuan; Zhiqiao Wang; Jin Gao
Journal:  Front Mol Neurosci       Date:  2022-04-14       Impact factor: 5.639

5.  Probing Neuro-Endocrine Interactions Through Remote Magnetothermal Adrenal Stimulation.

Authors:  Lisa Y Maeng; Dekel Rosenfeld; Gregory J Simandl; Florian Koehler; Alexander W Senko; Junsang Moon; Georgios Varnavides; Maria F Murillo; Adriano E Reimer; Aaron Wald; Polina Anikeeva; Alik S Widge
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

6.  Association Between Polymorphisms in Estrogen Receptor Genes and Depression in Women: A Meta-Analysis.

Authors:  Cuifen Li; Manli Xie; Weiwei Wang; Yanyan Liu; Dan Liao; Jingwen Yin; Hao Huang
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

7.  Impact of Mycotoxin Contaminations on Aquatic Organisms: Toxic Effect of Aflatoxin B1 and Fumonisin B1 Mixture.

Authors:  Davide Di Paola; Carmelo Iaria; Fabiano Capparucci; Alessia Arangia; Rosalia Crupi; Salvatore Cuzzocrea; Nunziacarla Spanò; Enrico Gugliandolo; Alessio Filippo Peritore
Journal:  Toxins (Basel)       Date:  2022-07-29       Impact factor: 5.075

8.  Potential Mechanisms of Shu Gan Jie Yu Capsule in the Treatment of Mild to Moderate Depression Based on Systemic Pharmacology and Current Evidence.

Authors:  Taiping Li; Tian Qiu; Yanyan Zeng; Bing Kang; Xianglong Tang; Ning Yang; Hong Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-22       Impact factor: 2.650

9.  Mechanism of saikogenin G against major depressive disorder determined by network pharmacology.

Authors:  Lili Hu; Jue Wang; Xiaoge Zhao; Donghui Cai
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

Review 10.  Hormones and Sex-Specific Medicine in Human Physiopathology.

Authors:  Maria Raza Tokatli; Leuconoe Grazia Sisti; Eleonora Marziali; Lorenza Nachira; Maria Francesca Rossi; Carlotta Amantea; Umberto Moscato; Walter Malorni
Journal:  Biomolecules       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.